Position in SVTR
Snapshot 2026-10-20- Investor SignalsRankedof 2,741↓23
- Life SciencesFactual rankingTop 5%–
6 confirmed deals in 24 months
🔒 Sign in for the exact rank and neighbours★ SVTR RatingSVTR has evaluated this company
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
AI investments
Deals by year
By round
By sector
By region
6 companies · 7 deals
| Suki | Series D+ | $90M | 2026-10 |
| Qualified Health | Series B | $125M | 2026-03 |
| Amae Health | Series B | $25M | 2025-11 |